Fevertree Drinks (LON:FEVR - Get Free Report) had its target price hoisted by investment analysts at JPMorgan Chase & Co. from GBX 770 to GBX 850 in a report released on Friday,Digital Look reports. The firm presently has a "neutral" rating on the stock. JPMorgan Chase & Co.'s price objective indicates a potential downside of 4.39% from the company's current price.
Fevertree Drinks Price Performance
Shares of FEVR stock opened at GBX 889 on Friday. The stock's fifty day simple moving average is GBX 893.09 and its 200 day simple moving average is GBX 841.44. The company has a debt-to-equity ratio of 1.50, a current ratio of 4.11 and a quick ratio of 3.21. The firm has a market cap of £1.05 billion, a price-to-earnings ratio of 4,263.79, a P/E/G ratio of -4.51 and a beta of 1.07. Fevertree Drinks has a one year low of GBX 608.50 and a one year high of GBX 1,020.
Fevertree Drinks (LON:FEVR - Get Free Report) last announced its quarterly earnings results on Thursday, September 11th. The company reported GBX 6.85 EPS for the quarter. Fevertree Drinks had a return on equity of 9.30% and a net margin of 6.05%. On average, analysts expect that Fevertree Drinks will post 38.3184173 earnings per share for the current fiscal year.
About Fevertree Drinks
(
Get Free Report)
Fevertree Drinks PLC, together with its subsidiaries, engages in the development and sale of premium mixer drinks in the United Kingdom, the United States, rest of Europe, and internationally. It offers Indian, Mediterranean, summer garden, elderflower, cucumber, damson and sloe berry, rhubarb and raspberry, aromatic, lemon, and Clementine tonic water products; pink grapefruit, soda water, raspberry and orange blossom, Mexican lime, Italian blood orange, white grape and apricot sodas; Silician, premium, and Madagascan cola and lemonades; British apple with garden mint, ginger, Sicilian lemonade, sparkling Mexican lime, Italian white grape and apricot, and light raspberry and rose lemonade softdrinks; and gingers.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Fevertree Drinks, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fevertree Drinks wasn't on the list.
While Fevertree Drinks currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.